News
📈 Stocks
Braveheart Biotech Prices $382.5 Million Upsized IPO, Signaling Strong Demand
(51 days ago)
Braveheart Biotech's $382.5 million upsized IPO underscores robust demand for biotech offerings and may boost sector ETFs like IBB.